Business Description
Evommune is a Palo Alto-based biotech company focused on treating chronic inflammatory conditions such as hives, eczema, and ulcerative colitis. Its two lead drug candidates, EVO756 and EVO301, are currently in clinical testing and aim to address the root causes of these diseases rather than just their symptoms. Founded in 2020, the company is still in the early stages of bringing its treatments to market.
